Skip to main content

Table 3 Cost outcomes

From: Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center

Characteristic

Total (n = 100)

Isavuconazole (n = 33)

Voriconazole (n = 34)

Posaconazole (n = 33)

P-value

Total drug cost, $

3912 [2499; 6635]

3570 [2476; 6458]

3891 [3013; 4904]

4798 [2546; 8011]

0.360

Total drug cost per day, $

478 [369; 625]

500 [396; 625]

369 [302; 474]

624 [485; 787]

< 0.001

Therapeutic drug monitoring, n (%)

22 (22)

0 (0)

14 (41.2)

8 (24.2)

< 0.001

Total cost, $

4032 [2499; 6703]

3571 [2476; 6458]

4011 [3013; 4904]

4798 [2546; 8131]

0.360

  1. Medians with IQR